Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease.

ABSTRACT:

Background

Antianginal medications are a class I recommendation by the American College of Cardiology/American Heart Association guidelines for stable ischemic heart disease. We sought to better understand guidance in drug selection and real-life outcomes of antianginal medication use.

Hypothesis

In patients with stable ischemic heart disease, antianginal medications lower mortality.

Methods

We evaluated 5608 patients with obstructive coronary artery disease (CAD) on elective cardiac catheterization with follow-up through self-administered questionnaires. Patients were classified as being prescribed a particular medication if they received that medication at index catheterization, or within 3 months postcatheterization. The association between antianginal medication u

SUBMITTER: Shen L 

PROVIDER: S-EPMC6490842 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature